Determining the receptor status of a breast cancer is crucial for guiding treatment. Hormone receptor-positive cancers may respond well to hormone therapy, which includes medications that lower estrogen levels or block estrogen from supporting the growth of cancer cells. In contrast, hormone receptor-negative cancers do not rely on estrogen and progesterone, and thus, hormone therapies are ineffective.
